What to Expect from Diabetes Tech in 2025

It’s safe to say that 2025 is shaping up to be a transformative year for diabetes technology! I spoke with Gary Scheiner, a Certified Diabetes Care and Education Specialist (CDCES) and author of Think Like a Pancreas, about the innovations and upgrades he expects will land in 2025 and how they will improve the lives of people with diabetes. 

We had a lot to cover in this conversation. With so many innovations on the horizon, Gary detailed several key updates from industry leaders as well as what to expect from some exciting new players in the mix, including:

• Medtronic's latest pump announcements: the MiniMed 8-Series pump with phone control headed into pivotal trials and a 7-day patch pump designed to hold 300 units of insulin.

• Medtronic’s new Simplera CGM and its upcoming CGM collab with Abbott.

• Tandem Diabetes Care is working on improving algorithm flexibility, allowing for more user control over boluses and basal adjustments that allow more user flexibility with activity, glycemic food variability and other daily decision making. We also discuss a future extended infusion set and when we can expect it.

• The twiist pump, featuring glycemic control, an advanced occlusion technology, and its cleared Tidepool Loop algorithm.

• Dexcom’s partnership with Oura Ring and how it could change the game by combining glucose data with stress, sleep, and activity, helping us see the cause-and-effect patterns behind our blood sugar levels.

• AI integrations with the Stelo CGM. 

Listen to this latest podcast episode to hear more about how competition is raising the bar to bring the very best in next gen tech. From innovation in non-invasive technology to improved tubeless pump therapy, you won’t want to miss how companies like Medtronic, Omnipod, Oura, Tandem, Abbot, twiist, Dexcom, and others are upping the ante for diabetes care.